(Q43420406)

23 November 2017

"White coat compliance" limits the reliability of therapeutic drug monitoring in HIV-1-infected patients (English)

1 reference

23 November 2017

Thomas J Podsadecki

1

1 reference

23 November 2017

Bernard C Vrijens

2

1 reference

23 November 2017

Eric P Tousset

3

1 reference

23 November 2017

Richard A Rode

4

1 reference

23 November 2017

George J Hanna

5

1 reference

23 November 2017

1 July 2008

1 reference

23 November 2017

1 reference

23 November 2017

9

1 reference

23 November 2017

4

1 reference

23 November 2017

238-246

1 reference

Position paper on therapeutic drug monitoring of antiretroviral agents

23 November 2017

1 reference

https://api.crossref.org/works/10.1310%2FHCT0904-238

Treatment for adult HIV infection: 2006 recommendations of the International AIDS Society-USA panel.

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FHCT0904-238

Pharmacokinetic-pharmacodynamic analysis of lopinavir-ritonavir in combination with efavirenz and two nucleoside reverse transcriptase inhibitors in extensively pretreated human immunodeficiency virus-infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FHCT0904-238

A lopinavir/ritonavir-based once-daily regimen results in better compliance and is non-inferior to a twice-daily regimen through 96 weeks

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FHCT0904-238

Comparing compliance patterns between randomized treatments.

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FHCT0904-238

Successful projection of the time course of drug concentration in plasma during a 1-year period from electronically compiled dosing-time data used as input to individually parameterized pharmacokinetic models

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FHCT0904-238

Prediction of diltiazem plasma concentration curves from limited measurements using compliance data

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FHCT0904-238

The impact of compliance in pharmacokinetic studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FHCT0904-238

21 January 2018

Identifiers

DOI

10.1310/HCT0904-238

1 reference

23 November 2017

1 reference